Subscribe for great stories in your community!
Harmony Biosciences, a Plymouth Meeting-based pharmaceutical company, has entered into an exclusive licensing deal for the rights to develop and commercialize a new potential…
Scorpion Capital filed a citizens petition with the U.S. Food and Drug Administration asking to have the federal agency reverse its approval of Plymouth…
Harmony Biosciences Holdings in Plymouth Meeting has agreed to buy Zynerba Pharmaceuticals for up to $200 million, writes John George for Philadelphia Business Journal.
Under…
The five buildings that comprise the Plymouth Meeting Executive Campus are on the market, and a ballpark valuation sees more than $100 million as a…
Two Montgomery County companies are among the winners of the inaugural Fire Awards presented by the Philadelphia Business Journal, writes Lisa Dukart for the publication…
Shares of Plymouth Meeting-based Harmony Biosciences Holdings soared as much as 70 percent over the public offering price on the stock’s first day…
Plymouth Meeting-based Harmony Biosciences, which markets the drug Wakix for patients with narcolepsy, is planning to raise $100 million with an initial public stock…
They’re raising a lot more than your average crops on this ‘pharm.’ A new drug designed to combat narcolepsy at the core of the…
Before we send you to this site, please subscribe to our daily newsletter.